The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-13 of 13 articles
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabaté M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L,
Brugaletta S,
Giacchi G,
Ishida K,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Valgimigli M,
Serruys P,
Sabaté M
August 4, 2017 | 10.4244/EIJ-D-16-00512
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis
Naber C,
Pyxaras SA,
Ince H,
Frambach P,
Colombo A,
Butter C,
Gatto F,
Hink U,
Nickenig G,
Bruschi G,
Brueren G,
Tchetché D,
den Heijer P,
Schillinger W,
Scholtz S,
Van der Heyden J,
Lefèvre T,
Gilard M,
Kuck K,
Schofer J,
Divchev D,
Baumgartner H,
Asch F,
Wagner M,
Latib A,
De Marco F,
Kische S
December 9, 2016 | 10.4244/EIJ-D-15-00511
Four-year experience with the CoreValve transcatheter heart valve
Kovac J,
Schuler G,
Gerckens U,
Müller R,
Serruys P,
Bonan R,
Labinaz M,
den Heijer P,
Mullen M,
Tymchak W,
Grube E
October 10, 2016 | 10.4244/EIJY15M10_10
Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis
Naber C,
Pyxaras SA,
Ince H,
Latib A,
Frambach P,
den Heijer P,
Wagner M,
Butter C,
Colombo A,
Kische S
February 12, 2016 | 10.4244/EIJV11I11A254
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study
Baumbach A,
Mullen M,
Brickman A,
Aggarwal S,
Pietras C,
Forrest J,
Hildick-Smith D,
Meller S,
Gambone L,
den Heijer P,
Margolis P,
Voros S,
Lansky AJ
May 19, 2015 | 10.4244/EIJY15M04_01
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction
Sabaté M,
Cequier A,
Iñiguez A,
Serra A,
Hernández-Antolín R,
Mainar V,
Valgimigli M,
Tespili M,
den Heijer P,
Bethencourt A,
Vazquez N,
Brugaletta S,
Backx B,
Serruys P
December 30, 2011 | 10.4244/EIJV7I8A154
A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System® frame and its application in patients with 1-year minimum follow-up
Piazza N,
Grube E,
Gerckens U,
Schuler G,
Linke A,
den Heijer P,
Kovacs J,
Spyt T,
Laborde J-C,
Morel M,
Nuis R,
Garcia-Garcia HM,
de Jaegere P,
Serruys P
January 15, 2010
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval
Piazza N,
Grube E,
Gerckens U,
den Heijer P,
Linke A,
Luha O,
Ramondo A,
Ussia G,
Wenaweser P,
Windecker S,
Laborde J-C,
de Jaegere P,
Serruys P
August 20, 2008
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™
Duckers H,
Soullié T,
den Heijer P,
Rensing B,
de Winter R,
Rau M,
Mudra H,
Silber S,
Benit E,
Verheye S,
Wijns W,
Serruys P
November 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent
Duckers H,
Silber S,
de Winter R,
den Heijer P,
Rensing B,
Rau M,
Mudra H,
Benit E,
Verheye S,
Wijns W,
Serruys P
May 22, 2007
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)
Aoki J,
Ong ATL,
Abizaid A,
den Heijer P,
Bonnier H,
McClean DR,
Verheye S,
Belardi J,
Condado J,
Pieper M,
Eduardo Sousa J,
Bressers M,
Symons J,
Litvack F,
Sianos G,
Serruys P
August 20, 2005
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022